Inspired by the Japanese art of kirigami, an MIT team has designed a technique that could transform flat panels into medical devices, habitats, and other objects without the use of tools.

Fittingly, the puzzle has begun reusing words on Groundhog Day, and it chose the very first Wordle answer ever to use again. CNET editor Gael Fashingbauer Cooper, a journalist and pop-culture junkie, ...

Actor Matt Damon claimed that Netflix requests that its films reiterate the plot "three or four times" in scenes to accommodate viewers on their phones. Damon and his longtime friend and fellow actor ...

Ben Affleck and Matt Damon are currently on the press tour for their new Netflix cop drama The Rip, an itinerary that included a beefy two-and-a-half-hour stop this past Friday on The Joe Rogan ...

In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over last year's supply shortage of the company's leading diabetes product. Leach ...

The protests in Iran are persisting in the face of the regime’s indiscriminate violence. President Trump has vowed to strike Iran for killing protesters; he has also said he wants to have talks. The ...

Everything was going so well. The Ohio State Buckeyes, fresh off a 2024 national championship, spent all of one day of the 2025 season out of the No. 1 spot. They evicted Texas from the penthouse in ...

From US President Donald Trump’s trade war to AI developments, 2025 has been full of dramatic twists and turns. One of the most consequential takeaways is to never, ever underestimate China. At the ...

Through all the tumult and drama, the 2025 Philadelphia Eagles have emerged with a history-making playoff berth. The Eagles defeated the Washington Commanders, 29-18, on Saturday to clinch ...

Over the last two decades, each NFC East team has accomplished at least something of note. The Giants and Eagles have won two Super Bowls each; the Cowboys have racked up a slew of 10-win seasons; ...

Andrew Zelenetz, MD, PhD, discusses the dual strategy of using the duration of benefit metric and re-biopsy to navigate complex sequencing decisions in targeted lymphoma therapy. A central challenge ...